Navigation Links
CSL Behring Recognized as a "Pioneer" By European Organisation for Rare Diseases (EURORDIS)
Date:3/1/2012

BRUSSELS, March 1, 2012 /PRNewswire/ -- CSL Behring is the recipient of a 2012 EURORDIS Award for its pioneering work in developing and manufacturing therapies used to treat rare and serious medical conditions. The global biotherapeutics company, which specializes in plasma-derived and recombinant therapies used to treat congenital bleeding disorders, immune deficiencies, hereditary angioedema and inherited respiratory disease, is a subsidiary of CSL Limited (ASX:CSL).

(Logo:  http://photos.prnewswire.com/prnh/20100914/PH63692LOGO )

One of the primary criteria for the award is a demonstrated commitment to providing access to therapies for people with rare diseases. The award was presented yesterday at the first EURORDIS Gala Dinner in the Hotel Le Plaza. "Solidarity," the theme of 2012 Rare Disease Day, focuses on the importance and the need for collaboration in the field of rare diseases.

"CSL Behring is honored and delighted to receive a 2012 EURORDIS Award," said Senior Vice President of Public Affairs Dennis Jackman. "This award is a reflection of our commitment to providing safe and effective therapies to improve the lives of patients with rare and serious medical conditions.  CSL Behring's commitment is further demonstrated in the company's growing investment in research and development, which has added to an extensive rare disease product portfolio, and in advanced manufacturing facilities and patient support."

CSL Behring received the National Organization for Rare Disorders 2011 Corporate Award for new treatments for rare diseases brought to market in the U.S.

About EURORDIS

EURORDIS is a non-governmental, patient-driven alliance of patient organisations and individuals active in the field of rare diseases, dedicated to improving the quality of life
'/>"/>

SOURCE CSL Behring
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2

Related medicine technology :

1. First Patient Screened in CSL Behring Global Phase I/III Study of Recombinant Single-Chain Factor VIII
2. CSL Behring Receives FDA Orphan Drug Designation for rVIIa-FP, a Novel Therapy in Development to Treat Hemophilia A and Hemophilia B Patients Who Have Inhibitors
3. CSL Behring Receives FDA Approval of Expanded Label on Berinert® for Self-administration and Treatment of Acute Laryngeal Attacks of Hereditary Angioedema
4. CSL Behring Seeks Proposals for Interlaken Leadership Awards, Supporting Innovative Research Into Neuroimmunology
5. CSL Behring Receives EU Orphan Drug Designations for rVIIa-FP for Hemophilia A and B Treatment
6. National Organization for Rare Disorders Presents CSL Behring With 2011 Corporate Award
7. CSL Behring Marks World Hemophilia Day with Coagulation Factor Donation to World Federation of Hemophilia
8. CSL Behring Medical Product Donation Helps Meet Critical Need for Ongoing Cholera Relief Effort in Haiti
9. CSL Behring Announces Completion of National Marketing Authorizations of Berinert® After MRP in 23 European Countries
10. CSL Behring Announces FDA Approval of Berinert(R), First and Only Therapy Approved for the Treatment of Acute Abdominal and Facial Attacks of Hereditary Angioedema in U.S.
11. CSL Behring Receives Orphan-Drug Exclusivity for RiaSTAP(TM), First and Only Approved Treatment of Acute Bleeding Episodes in Patients with Congenital Fibrinogen Deficiency
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/19/2014)... , Dec. 18, 2014  Decision Resources Group ... the United States will increase to a ... be primarily driven by expansion in the large direct ... devices will be increasingly adopted due to the advantages ... Other key findings from Decision Resources Group,s coverage ...
(Date:12/19/2014)... , Dec. 18, 2014 Since last month,s ... site now known as the leading online black market ... explosive growth in its offering of drugs and other ... show the takedowns did succeed in lowering the numbers ... review of the markets in August. But some new ...
(Date:12/17/2014)... and SAN DIEGO , Dec. ... PHG ; AEX: PHIA) and Volcano Corporation (NASDAQ: ... measurement solutions for cardiovascular applications, today announced that they have ... Philips will commence a tender offer to acquire all of ... per share, or a total equity purchase price of USD ...
Breaking Medicine Technology:U.S. Laparoscopic Device Market Will Reach Over $4.3 Billion by 2023 2U.S. Laparoscopic Device Market Will Reach Over $4.3 Billion by 2023 3Post Silk Road - Another Online Drug Den Now Dominates the DarkNet 2Post Silk Road - Another Online Drug Den Now Dominates the DarkNet 3Philips to acquire Volcano to expand global leadership position in image-guided therapy market 2Philips to acquire Volcano to expand global leadership position in image-guided therapy market 3Philips to acquire Volcano to expand global leadership position in image-guided therapy market 4Philips to acquire Volcano to expand global leadership position in image-guided therapy market 5Philips to acquire Volcano to expand global leadership position in image-guided therapy market 6Philips to acquire Volcano to expand global leadership position in image-guided therapy market 7Philips to acquire Volcano to expand global leadership position in image-guided therapy market 8
... throughout cities nationally, LOS ANGELES and ... a wholly owned subsidiary of SpineMark Corporation, ... to create the,nation,s first multidisciplinary, multisite Spine ... spine experts under one organization.,The SpineMark SROs ...
... present interim results of the Cethrin(R) Phase ... HOPKINTON, Mass., April 9, 2008 Alseres,Pharmaceuticals, Inc. (Nasdaq: ... Dr.,Mark Hurtt, Chief Medical Officer, will discuss the CETHRIN ... Spinal Cord Injury Research,during a congressional briefing on Capitol ...
Cached Medicine Technology:SpineMark Partners With Regional Spine Leaders to Launch Its First Multisite Spine Research Organizations in Los Angeles, Denver 2SpineMark Partners With Regional Spine Leaders to Launch Its First Multisite Spine Research Organizations in Los Angeles, Denver 3Alseres Pharmaceuticals, Inc. to Address a Congressional Briefing on Paralysis Research and the Spinal Cord Injury Community at 'Working 2 Walk' in Washington, DC, April 13-15, 2008 2Alseres Pharmaceuticals, Inc. to Address a Congressional Briefing on Paralysis Research and the Spinal Cord Injury Community at 'Working 2 Walk' in Washington, DC, April 13-15, 2008 3Alseres Pharmaceuticals, Inc. to Address a Congressional Briefing on Paralysis Research and the Spinal Cord Injury Community at 'Working 2 Walk' in Washington, DC, April 13-15, 2008 4
(Date:12/20/2014)... 20, 2014 Xarelto bleeding lawsuits ... uncontrollable bleeding and other serious side effects will ... of Louisiana for coordinated pretrial proceedings, Wright & Schulte ... (JPML) issued an order Friday to transfer 21 Xarelto ... 22 federal courts to the Louisiana district court for ...
(Date:12/20/2014)... Today, Balfleet.com, one of the most outstanding ... 50%-70% off on its Mother of the Bride ... of the bride dresses from Balfleet.com feature gorgeous looks ... and takes pride in providing high quality dresses to ... great discounts on our mother of the bride dresses, ...
(Date:12/19/2014)... December 20, 2014 Sweetdressy.com , ... has introduced its newest selection of cheap prom dresses ... very popular in the world and clients can buy ... Meanwhile, these prom dresses feature cool cuts and delicate ... now, targeting the middle-end market. Discount shipping costs are ...
(Date:12/19/2014)... Anaheim, CA (PRWEB) December 19, 2014 ... not-for-profit corporation dedicated to developing educational events, tools ... and Rouxbe Cooking School , the world’s ... develop the prescription every human being needs: Culinary ... and plant-based cooking course, Culinary Rx, scheduled for ...
(Date:12/19/2014)... Eufaula, Oklahoma, located just 9 miles ... state’s largest lake with more than 600 miles of ... a little more than 3,000 residents, hosted its annual ... 6th of December. , Featuring Santa, Christmas lights and ... on Main Street. Narconon Arrowhead’s parade float participated ...
Breaking Medicine News(10 mins):Health News:Xarelto Bleeding Lawsuits Consolidated To Louisiana Federal Court For Multi-District Litigation Reports Wright & Schulte LLC 2Health News:Xarelto Bleeding Lawsuits Consolidated To Louisiana Federal Court For Multi-District Litigation Reports Wright & Schulte LLC 3Health News:Xarelto Bleeding Lawsuits Consolidated To Louisiana Federal Court For Multi-District Litigation Reports Wright & Schulte LLC 4Health News:Balfleet.com is Offering 50%-70% Off of its Mother of the Bride Dresses 2Health News:Cheap Prom Dresses Online Now at Sweetdressy.com 2Health News:The Plantrician Project and the Rouxbe Cooking School Join Forces to Develop Culinary Rx – a Plant-Prescription Course 2Health News:The Plantrician Project and the Rouxbe Cooking School Join Forces to Develop Culinary Rx – a Plant-Prescription Course 3Health News:The Plantrician Project and the Rouxbe Cooking School Join Forces to Develop Culinary Rx – a Plant-Prescription Course 4Health News:Narconon Arrowhead Debuts Float at Checotah and Eufaula Christmas Parades 2Health News:Narconon Arrowhead Debuts Float at Checotah and Eufaula Christmas Parades 3
... could produce treatments to reduce cravings, expand calorie burn ... that breaks down and suppresses an appetite stimulant produced ... with The Scripps Research Institute say the antibody catalyst, ... curbed their eating even after the rodents went 24 ...
... Day Bond Referendum to,Support Water, Sewage Systems, ... pointed to a report issued today that measures ... sewer infrastructure and,warns of an impending crisis unless ... systems., The report, compiled by the Sustainable ...
... Physical therapy is a cost-effective form of ... Oct. 31 Patients with,diabetes who participate ... resistance exercise demonstrate improvements in glucose control,physical ... a study,published in the November 2008 issue ...
... Nutrition 21, Inc.,(Nasdaq: NXXI ), a developer and ... levels, improve cardiovascular health,enhance memory and address chronic joint ... opening of the market -- on Thursday,November 13, 2008 ... 30, 2008. The Company has scheduled a conference call ...
... people thought certain illnesses were more dangerous if publicized ... greatly influences how people perceive the threat of infectious ... receive extensive coverage are likely to be regarded as ... the case. , "The media tend to focus on ...
... Blue Cross Blue Shield of Michigan has,closed its Detroit-based ... morning., The closings affect Blue Cross buildings on ... Service Center,buildings. The company,s office building on Jefferson Avenue ... in the impacted facilities are,being sent home for the ...
Cached Medicine News:Health News:Scientists Develop New Strategy to Fight Obesity 2Health News:Governor's Task Force Cites PA's $36.5 Billion Water Infrastructure Need; Report Underscores Call for Additional Investments 2Health News:Governor's Task Force Cites PA's $36.5 Billion Water Infrastructure Need; Report Underscores Call for Additional Investments 3Health News:New Research Shows That Combining Aerobic Exercise With High-Force Eccentric Resistance Training Improves Glucose Control in Diabetes Patients 2Health News:New Research Shows That Combining Aerobic Exercise With High-Force Eccentric Resistance Training Improves Glucose Control in Diabetes Patients 3Health News:Nutrition 21 to Report Preliminary First Quarter Fiscal Year 2009 Financial Results on Thursday, November 13, 2008 2Health News:Media Affects Public Perception of Infectious Diseases 2
... Guglielmi Detachable Coil is intended for: embolization ... of,their morphology, their location, or the patient's ... the treating,neurosurgical team to be a) very ... techniques, or b) inoperable.,The GDC is also ...
Designed to have a shock-absorbing force, providing less bounce or wasted force....
Slightly curved Periosteal elevator....
Set of 5 large bone curettes. One each of the following: angled small, straight small, angled medium, straight medium, and angled large....
Medicine Products: